EGR1 (Protein|Antibody|cDNA Clone|ELISA Kit)

All EGR1 reagents are produced in house and quality controlled, including 2 EGR1 Antibody, 21 EGR1 Gene, 1 EGR1 qPCR. All EGR1 reagents are ready to use.

EGR1 antibodies are validated with different applications, which are ICC/IF, IF, WB.

EGR1 cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each EGR1 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.

EGR1 Antibody (2)

Application Clonality

Anti-EGR1 Antibody


Specificity: Human

Application: WB

Clonality: PAb

Human EGR1 Western blot (WB) 18033

Anti-EGR1 Antibody


Specificity: Human

Application: ICC/IF,IF

Clonality: PAb

Human EGR1 Immunohistochemistry(IHC) 3061

EGR1 cDNA Clone (21)


EGR1 qPCR Primer (1)

Early growth response 1 (EGR1) is an early response transcriptional regulator that can be rapidly induced by various environmental stimuli, the increase of EGR1 expression in epithelial cells is a common stress induced, cell type specific response upon host-bacteria interaction that is mediated by EGFR-ERK1/2 and beta1-integrin signaling. Early growth response 1 (Egr1) is a key transcription factor that mediates the action of estrogen (E2) to establish uterine receptivity for embryo implantation. Early growth response transcription factor 1 (EGR1) is expressed in the suprachiasmatic nucleus (SCN) after light stimulation, the circadian clock in the SCN is disturbed in mice deficient of EGR1. The transcription factor EGR1 (early growth response 1) is a member of a zinc finger transcription factor family which plays an essential role in cell growth and proliferation. EGR1 expression levels in human gliomas are decreased compared with normal brain tissues, however, the patients with low EGR1 expression level showed significantly enhanced patient survival in all glioma patients. EGR1 silencing inhibited proliferation and induced G1 phase arrest in glioma cells.